Survival analysis ranked the cumulative overall survival time as follows: high AP4 + high LAPTM4B < high AP4 + low LAPTM4B < low AP4 + high LAPTM4B < low AP4 + low LAPTM4B in HCC. This evidence concerns the gene TFAP4 and hepatocellular carcinoma.